Ohaegbulam K, Anderson C, Thompson RF, Mitin T, et al. Common Medical Comorbidities Influence Pneumonitis Risk After Chemoradiotherapy and Durvalumab Maintenance in Stage III Non-small Cell Lung Cancer. Clin Lung Cancer 2025 Apr 24:S1525-7304(25)00082.
PMID: 40374425